Cancer-associated loss-of-function mutations implicate DAPK3 as a tumor-suppressing Kinase

Cancer Research

Volumn 71, Issue 8, 2011, Pages 3152-3161

  Brognard, John ^a,b,d   Zhang, You Wei ^b,c   Puto, Lorena A ^b   Hunter, Tony ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; ASPARTIC ACID; ETOPOSIDE; METHIONINE; PROLINE; SERINE; THREONINE;

ARTICLE; BIOINFORMATICS; CANCER CELL CULTURE; CANCER RESISTANCE; CELL AGGREGATION; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DAPK3 GENE; DRUG SENSITIVITY; ENZYME ACTIVITY; LOSS OF FUNCTION MUTATION; LUNG NON SMALL CELL CANCER; MUTANT; NEOPLASM; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE; WILD TYPE;

AMINO ACID SEQUENCE; APOPTOSIS REGULATORY PROTEINS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; HELA CELLS; HUMANS; LUNG NEOPLASMS; MOLECULAR SEQUENCE DATA; MUTATION; TUMOR SUPPRESSOR PROTEINS;

EID: 79954580266     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-3543     Document Type: Article

References (28)

1. Bonetta L. Whole-genome sequencing breaks the cost barrier. Cell 141:917-9.
2. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, et al. A census of human cancer genes. Nat Rev Cancer 2004;4:177-83. (Pubitemid 38337497)
3. Boland CR, Goel A. Somatic evolution of cancer cells. Semin Cancer Biol 2005;15:436-50. (Pubitemid 41318044)
4. Stuart D, Sellers WR. Linking somatic genetic alterations in cancer to therapeutics. Curr Opin Cell Biol 2009;21:304-10.
5. Ferrer-Costa C, Gelpi JL, Zamakola L, Parraga I, de la Cruz X, Orozco M. PMUT: A web-based tool for the annotation of pathological mutations on proteins. Bioinformatics 2005;21:3176-8. (Pubitemid 41418475)
6. Kaminker JS, Zhang Y, Watanabe C, Zhang Z. CanPredict: A computational tool for predicting cancer-associated missense mutations. Nucleic Acids Res 2007;35:W595-8.
7. Kaminker JS, Zhang Y, Waugh A, Haverty PM, Peters B, Sebisanovic D, et al. Distinguishing cancer-associated missense mutations from common polymorphisms. Cancer Res 2007;67:465-73. (Pubitemid 46192182)
8. Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, et al. Patterns of somatic mutation in human cancer genomes. Nature 2007;446:153-8. (Pubitemid 46398669)
9. Bialik S, Kimchi A. The death-associated protein kinases: Structure, function, and beyond. Annu Rev Biochem 2006;75:189-210. (Pubitemid 44118031)
10. Kögel D, Bierbaum H, Preuss U, Scheidtmann KH. C-terminal truncation of Dlk/ZIP kinase leads to abrogation of nuclear transport and high apoptotic activity. Oncogene 1999;18:7212-8. (Pubitemid 30032099)
11. Kawai T, Matsumoto M, Takeda K, Sanjo H, Akira S. ZIP kinase, a novel serine/threonine kinase which mediates apoptosis. Mol Cell Biol 1998;18:1642-51. (Pubitemid 28100930)
12. Raval A, Tanner SM, Byrd JC, Angerman EB, Perko JD, Chen SS, et al. Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell 2007;129:879-90. (Pubitemid 46813150)
13. Rossi D, Gaidano G, Gloghini A, Deambrogi C, Franceschetti S, Berra E, et al. Frequent aberrant promoter hypermethylation of O6-methylguanine-DNA methyltransferase and death-associated protein kinase genes in immunodeficiency-related lymphomas. Br J Haematol 2003;123:475-8. (Pubitemid 37363490)
14. Ng MH, To KW, Lo KW, Chan S, Tsang KS, Cheng SH, et al. Frequent death-associated protein kinase promoter hypermethylation in multiple myeloma. Clin Cancer Res 2001;7:1724-9. (Pubitemid 32708641)
15. Pike AC, Rellos P, Niesen FH, Turnbull A, Oliver AW, Parker SA, et al. Activation segment dimerization: A mechanism for kinase autophosphorylation of non-consensus sites. EMBO J 2008;27: 704-14. (Pubitemid 351273130)
16. Gao T, Furnari F, Newton AC. PHLPP: A phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol Cell 2005;18:13-24. (Pubitemid 40444644)
17. Murata-Hori M, Fukuta Y, Ueda K, Iwasaki T, Hosoya H. HeLa ZIP kinase induces diphosphorylation of myosin II regulatory light chain and reorganization of actin filaments in nonmuscle cells. Oncogene 2001;20:8175-83. (Pubitemid 34038206)
18. Graves PR, Winkfield KM, Haystead TA. Regulation of zipper-interacting protein kinase activity in vitro and in vivo by multisite phosphorylation. J Biol Chem 2005;280:9363-74. (Pubitemid 40409630)
19. Preuss U, Landsberg G, Scheidtmann KH. Novel mitosis-specific phosphorylation of histone H3 at Thr11 mediated by Dlk/ZIP kinase. Nucleic Acids Res 2003;31:878-85. (Pubitemid 36240425)
20. Brognard J, Clark AS, Ni Y, Dennis PA. Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res 2001;61:3986-97. (Pubitemid 32720961)
21. Gozuacik D, Kimchi A. DAPk protein family and cancer. Autophagy 2006;2:74-9.
22. Westhoff MA, Zhou S, Bachem MG, Debatin KM, Fulda S. Identification of a novel switch in the dominant forms of cell adhesionmediated drug resistance in glioblastoma cells. Oncogene 2008; 27:5169-81.
23. Lochhead PA, Wickman G, Mezna M, Olson MF. Activating ROCK1 somatic mutations in human cancer. Oncogene; 29:2591-8.
24. Zagorska A, Deak M, Campbell DG, Banerjee S, Hirano M, Aizawa S, et al. New roles for the LKB1-NUAK pathway in controlling myosin phosphatase complexes and cell adhesion. Sci Signal; 3:ra25.
25. Partanen JI, Nieminen AI, Makela TP, Klefstrom J. Suppression of oncogenic properties of c-Myc by LKB1-controlled epithelial organization. Proc Natl Acad Sci U S A 2007;104:14694-9. (Pubitemid 350003205)
26. Zhong D, Guo L, de Aguirre I, Liu X, Lamb N, Sun SY, et al. LKB1 mutation in large cell carcinoma of the lung. Lung Cancer 2006;53: 285-94. (Pubitemid 44189563)
27. Bi J, Lau SH, Hu L, Rao HL, Liu HB, Zhan WH, et al. Downregulation of ZIP kinase is associated with tumor invasion, metastasis and poor prognosis in gastric cancer. Int J Cancer 2009;124:1587-93.
28. Brognard J, Hunter T. Protein kinase signaling networks in cancer. Curr Opin Genet Dev 2011;21:4-11.